180 related articles for article (PubMed ID: 731437)
1. In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.
Székely JI; Dunai-Kovács Z; Miglécz E; Rónai AZ; Bajusz S
J Pharmacol Exp Ther; 1978 Dec; 207(3):878-83. PubMed ID: 731437
[TBL] [Abstract][Full Text] [Related]
2. Behavioral activating effects of opiates and opioid peptides.
Browne RG; Segal DS
Biol Psychiatry; 1980 Feb; 15(1):77-86. PubMed ID: 6101965
[TBL] [Abstract][Full Text] [Related]
3. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
4. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
Miglécz E; Székely JI; Dunai-Kovács Z
Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
[TBL] [Abstract][Full Text] [Related]
7. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
McGilliard KL; Takemori AE
J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of two enzyme resistant enkephalin analogs possessing enhanced analgesic activity.
Day AR; Carney JM; Rosecrans JA; Dewey WL; Freer RJ
Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):59-68. PubMed ID: 663409
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms mediating tail-flick inhibition induced by beta-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1991 Apr; 257(1):530-8. PubMed ID: 2020008
[TBL] [Abstract][Full Text] [Related]
13. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
Ohlsson AE; Fu TC; Jones D; Martin BR; Dewey WL
J Pharmacol Exp Ther; 1982 May; 221(2):362-7. PubMed ID: 6281413
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
Brady LS; Holtzman SG
J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of intrathecally administered human beta-endorphin in the rat and cat.
Yaksh TL; Henry JL
Can J Physiol Pharmacol; 1978 Oct; 56(5):754-9. PubMed ID: 581358
[TBL] [Abstract][Full Text] [Related]
16. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
McGilliard KL; Takemori AE
J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioid peptide inhibition of the central actions of angiotensin.
Summy-Long JY; Keil LC; Deen K; Rosella L; Severs WB
J Pharmacol Exp Ther; 1981 Jun; 217(3):619-29. PubMed ID: 6262492
[TBL] [Abstract][Full Text] [Related]
18. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.
Tallarida RJ; Harakal C; Maslow J; Geller EB; Adler MW
J Pharmacol Exp Ther; 1978 Jul; 206(1):38-45. PubMed ID: 660555
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.
Bolme P; Fuxe K; Agnati LF; Bradley R; Smythies J
Eur J Pharmacol; 1978 Apr; 48(3):319-24. PubMed ID: 639859
[TBL] [Abstract][Full Text] [Related]
20. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
